Viridian Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Viridian Therapeutics, Inc.‘s stocks are currently a part of 66 hedge funds’ portfolios, which represents 33.07% of the total amount of its stocks outstanding. This makes up a total of 10.61M shares of Viridian Therapeutics, Inc.. Compared to the previous quarter, the number fell by -74.31% or -30.68M shares fewer. As for the holding position changes, 39.39% (26) of current hedge fund investors increased the number of shares held, 24.24% (16) of current holders sold a part of the shares held, and 1.52% (1) closed the holdings completely. 17 hedge funds are new holders of Viridian Therapeutics, Inc. stock in Q1 2023, it is 25.76% of total holders.
Hedge funds holding Viridian Therapeutics (Q1 2017 – Q1 2023)
| Q1 2017 | 1 |
|---|---|
| Q2 2017 | 0 |
| Q4 2017 | 1 |
| Q1 2018 | 3 |
| Q2 2018 | 1 |
| Q3 2018 | 2 |
| Q4 2018 | 0 |
| Q3 2019 | 1 |
| Q4 2019 | 0 |
| Q4 2020 | 2 |
| Q1 2021 | 29 |
| Q2 2021 | 24 |
| Q3 2021 | 38 |
| Q4 2021 | 52 |
| Q1 2022 | 72 |
| Q2 2022 | 81 |
| Q3 2022 | 104 |
| Q4 2022 | 123 |
| Q1 2023 | 66 |
Hedge funds changes in Viridian Therapeutics positions (Q1 2017 – Q1 2023)
| Q1 2017 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2017 | 0 | 0 | 0 | 1 | -1 |
| Q4 2017 | 1 | 0 | 0 | 0 | 0 |
| Q1 2018 | 2 | 0 | 0 | 0 | 1 |
| Q2 2018 | 0 | 0 | 0 | 2 | -1 |
| Q3 2018 | 1 | 0 | 0 | 0 | 1 |
| Q4 2018 | 0 | 0 | 0 | 2 | -2 |
| Q3 2019 | 1 | 0 | 0 | 0 | 0 |
| Q4 2019 | 0 | 0 | 0 | 1 | -1 |
| Q4 2020 | 2 | 0 | 0 | 0 | 0 |
| Q1 2021 | 27 | 0 | 0 | 0 | 2 |
| Q2 2021 | 4 | 10 | 4 | 9 | -3 |
| Q3 2021 | 17 | 15 | 3 | 3 | 0 |
| Q4 2021 | 19 | 22 | 5 | 4 | 2 |
| Q1 2022 | 23 | 22 | 16 | 3 | 8 |
| Q2 2022 | 30 | 22 | 17 | 21 | -9 |
| Q3 2022 | 33 | 50 | 14 | 10 | -3 |
| Q4 2022 | 30 | 52 | 30 | 10 | 1 |
| Q1 2023 | 17 | 26 | 16 | 1 | 6 |
Hedge funds changes in Viridian Therapeutics stock options (Q1 2017 – Q1 2023)
| Q1 2017 | 0 | 0 |
|---|---|---|
| Q2 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 926,000 | 0 |
| Q4 2021 | 1,272,000 | 0 |
| Q1 2022 | 1,998,000 | 0 |
| Q2 2022 | 5,660,000 | 0 |
| Q3 2022 | 3,624,000 | 652,000 |
| Q4 2022 | 3,472,306 | 3,581,470 |
| Q1 2023 | 809,007,000 | 763,250,000 |